First mobile application - Lepra reaction basic management guide - Stress on steroids

First mobile application - Lepra reaction basic management guide - Stress on steroids

Bibliographic Details
Main Author:	Pugazhenthan Thangaraju
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Indian Journal of Drugs in Dermatology
Online Access:	http://www.ijdd.in/article.asp?issn=2455-3972;year=2018;volume=4;issue=2;spage=85;epage=86;aulast=Thangaraju

Similar Items

DSÖ lepra tedavi kılavuzu: farmakovijilansa odaklanma
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-06-01)

Mycobacterium leprae or Tuberculosis: A diagnostic dilemma
by: Pugazhenthan Thangaraju, et al.
Published: (2017-01-01)

Lepra tip 2 reaksiyonlarında talidomid tedavisinde ilaç yan etkisi olarak ikincil eosinofili: zorunlu bir sorumluluk
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-12-01)

Vigilance in selection of low-dose versus high-dose steroids in COVID-19
by: Pugazhenthan Thangaraju, et al.
Published: (2021-08-01)

Violence against doctor – few points to be focussed
by: Pugazhenthan Thangaraju
Published: (2020-01-01)

Two atypical presentations of lepra reactions
by: Vikas Pathania, et al.
Published: (2018-01-01)

News from regulatory corner: Safety communication and recent drug approvals
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01)

Leprosy in Children: Needs for Active Intervention
by: Pugazhenthan Thangaraju, et al.
Published: (2018-01-01)

Single-dose rifampicin: What current World Health Organization guidelines emphasis and practical special attention?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Medical residents: Research and publication priorities/confusions
by: Pugazhenthan Thangaraju, et al.
Published: (2020-01-01)

Cüzzamın yeniden alevlenmesine yönelik mücadele stratejileri: Vurgulanması gereken noktalar
by: Sajitha VENKATESAN, et al.
Published: (2019-12-01)

Responding to the Global Guidelines for the Prevention of Surgical Site Infection, 2018: A focus on surgical antibiotic prophylaxis prolongation
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Dünya Sağlık Örgütünün 2019'da küresel sağlığa tehdit ettiğini belirttiği on tehditten biri: Antimikrobiyal direnç
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-09-01)

Clofazimine induced methemoglobinemia –Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Government of India initiative against leprosy—We should be aware
by: Sajitha Venkatesan, et al.
Published: (2019-01-01)

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
by: Pugazhenthan Thangaraju, et al.
Published: (2017-01-01)

De novo histoid leprosy - Further points of focus
by: Sajitha Venkatesan, et al.

Current treatment guideline by the World Health Organization against leprosy: A positive focus
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Monotherapy with liraglutide – Points to be focussed
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

Lepra Reaction with Lucio Phenomenon Mimicking Cutaneous Vasculitis
by: Durga Prasanna Misra, et al.
Published: (2014-01-01)

Lepra
by: Efraím Otero Ruiz
Published: (1996-09-01)

“Deck chair sign” presenting in type 1 lepra reaction
by: Amina Asfiya, et al.
Published: (2021-01-01)

Use of the polymerase chain reaction to detect Mycobacterium leprae in urine
by: K.R. Caleffi, et al.
Published: (2012-02-01)

Use of the polymerase chain reaction to detect Mycobacterium leprae in urine
by: K.R. Caleffi, et al.
Published: (2012-02-01)

A retrospective analysis of histopathology of 64 cases of lepra reactions
by: Vijay Adhe, et al.
Published: (2012-01-01)

Lepra familiar
by: Richard Arrieta, et al.
Published: (2001-09-01)

LEPRA LEPROMATOSA
by: Juan Nájera Gómez, et al.
Published: (2017-12-01)

On psoriasis or lepra
by: Hewlett, W. H.
Published: (1898)

Structure-Guided Computational Approaches to Unravel Druggable Proteomic Landscape of Mycobacterium leprae
by: Sundeep Chaitanya Vedithi, et al.
Published: (2021-05-01)

LYMPHOCYTE RESPONSE TO Mycobacterium leprae ANTIGENS IN REVERSAL REACTION STATE OF LEPROSY
by: Irawan Yusuf, et al.
Published: (2015-07-01)

Livedo reticularis in type 2 lepra reaction: A rare presentation
by: Kikkeri Narayanasetty Naveen, et al.
Published: (2014-01-01)

Type 2 lepra reactions (ENL) presenting with extensive cutaneous ulcerations
by: Sapnashree Budhnoor Sreekantaiah, et al.
Published: (2012-01-01)

COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?
by: Pugazhenthan Thangaraju, et al.
Published: (2020-06-01)

Ebola virüsüne yönelik ilaç çalışmaları: bir umut ışığı
by: Pugazhenthan THANGARAJU, et al.
Published: (2019-12-01)

Chloroquine induced utricaria—A detailed history helps
by: Pugazhenthan Thangaraju, et al.
Published: (2019-01-01)

A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
by: Felix Aberer, et al.
Published: (2021-05-01)

Role of histopathology in predicting type 1 lepra reaction in borderline tuberculoid leprosy
by: Dhanya Sankaran, et al.
Published: (2020-01-01)

Lepra y paracoccidioidomicosis
by: E. de los A. Méndez, et al.
Published: (2007-12-01)

Lepra e tuberculose
by: H. C. de Souza Araujo
Published: (1941-01-01)